Latest On Gamida Cell Ltd (GMDA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-22 22:17 EST | News | Gamida Cell gets new finance chief | N/A |  |
| 2023-05-16 00:13 EST | News | Gamida Cell GAAP EPS of -$0.27 in-line | N/A | |
| 2023-05-16 00:13 EST | News | Gamida Cell Ltd. (GMDA) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-04-28 19:53 EST | News | Gamida: The Die Is Now Cast | N/A | |
| 2023-04-19 11:08 EST | News | Gamida Cell stock dips after pricing $23M securities offering | N/A | |
About Gamida Cell Ltd (GMDA):
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel.
General
- Name Gamida Cell Ltd
- Symbol GMDA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 110
- Fiscal Year EndDecember
- IPO Date2018-10-26
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.gamida-cell.com
Valuation
- Price/Book (Most Recent Quarter) 5.23
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.78
- Next Year EPS Estimate -$1.97
- Next Quarter EPS Estimate -$0.33
- Return on Assets -35%
- Return on Equity -109%
- Earnings Per Share -$3.20
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 515.63 million
- EBITDA -38606000
- Analyst Target Price $19
- Book Value Per Share $1.67
Share Statistics
- Shares Outstanding 59.2 million
- Shares Float 41.1 million
- % Held by Insiders 3184%
- % Held by Institutions 33.63%
- Shares Short 1.14 million
- Shares Short Prior Month 1.33 million
- Short Ratio 0.65
- Short % of Float 2%
- Short % of Shares Outstanding 2%
Technicals
- Beta 2.04
- 52 Week High $12.47
- 52 Week Low $2.73
- 50 Day Moving Average 9.56
- 200 Day Moving Average 7.32
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Gamida Cell Ltd (GMDA) Dividend Calendar:
Gamida Cell Ltd (GMDA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Gamida Cell Ltd (GMDA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Gamida Cell Ltd (GMDA) Chart:
Gamida Cell Ltd (GMDA) News:
Below you will find a list of latest news for Gamida Cell Ltd (GMDA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Gamida Cell Ltd (GMDA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest GMDA Trades:
Gamida Cell Ltd (GMDA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-05 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-11-02 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-10-13 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-10-06 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-09-14 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-09-10 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-08-14 | SC 13D/A (General statement of acquisition of beneficial ownership) | |
| 2020-08-12 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-08-10 | 6-K/A (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-08-06 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-07-21 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-07-13 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-07-10 | SC 13G/A (Statement of acquisition of beneficial ownership by individuals) | |
| 2020-05-26 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-05-26 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-05-22 | SC 13D/A (General statement of acquisition of beneficial ownership) | |
| 2020-05-21 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-05-20 | 424B5 (Prospectus [Rule 424(b)(5)]) | |
| 2020-05-20 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-05-18 | 424B5 (Prospectus [Rule 424(b)(5)]) | |